Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Medical Genetics

The Genetics of Wolf-Hirschhorn Syndrome: Deletions and Testing

At a Glance

Wolf-Hirschhorn syndrome results from a missing piece of chromosome 4 at 4p16.3. Microarray testing measures the deletion’s size and location, while parental chromosome testing helps show whether it happened by chance or came from a balanced chromosome swap.

Genetic testing can feel like a foreign language. When you are told your child has a deletion on chromosome 4, you are essentially being told that a small “instruction manual” for development is missing. Understanding the specifics of this deletion—how big it is (measured in units called megabases or Mb), which genes are gone, and how it happened—can help you and your medical team plan for the future.

The Missing Piece: 4p16.3

Each of us typically has 46 chromosomes, arranged in 23 pairs. One pair is “Chromosome 4.” Chromosomes have a short arm (called p) and a long arm (called q). Wolf-Hirschhorn syndrome (WHS) happens when a piece of the short arm is missing, specifically at a location called 4p16.3 [1][2].

Because this area contains several important genes, losing them affects how the body and brain develop. This is known as a contiguous gene syndrome, meaning the symptoms are associated with the combined loss of several neighboring genes rather than just one [2].

Key Genes and Their Associations

While many genes may be missing in a deletion, researchers have identified a few “heavy hitters” that contribute to the core features of WHS. It is important to remember that these are associations found across large groups, not perfect predictions for an individual:

  • NSD2 (formerly WHSC1): This gene is a master regulator. Its loss is strongly associated with the characteristic facial features, slow growth, and developmental delays seen in WHS [3][4].
  • LETM1: This gene helps manage the “batteries” of our cells (mitochondria). Its loss has been proposed as a major contributor to the seizure susceptibility seen in WHS, though losing it does not guarantee seizures will occur [5][6].
  • MSX1: This gene is involved in the development of the face and teeth. Its absence is a plausible contributor to dental issues or specific facial structures [7][2].

How We Find the Deletion: Testing Methods

Not all genetic tests are the same. You may hear your doctors talk about two main types:

  1. Chromosomal Microarray (CMA): This is a preferred, high-powered test that looks across the entire genome for missing or extra pieces of DNA [8]. It provides the exact coordinates and size of the deletion [9]. However, CMA cannot detect if chromosomes have simply swapped places without gaining or losing material.
  2. Karyotype: This is a test where scientists look at chromosomes under a microscope. While it can see large missing pieces or major structural changes, it often misses smaller WHS deletions [10][11].

Does Deletion Size Matter?

In general, cohort studies show a correlation between the size of the deletion and the severity of the symptoms, but it is not a perfect rule.

  • Larger Deletions (>9 Mb): Studies show that deletions larger than 9 Mb are often associated with more significant developmental delays and more frequent or severe epilepsy [12][13].
  • Small or “Interstitial” Deletions: Some children have an “interstitial” deletion, meaning a piece is missing from the middle of the arm rather than the tip (terminal deletion). These children may sometimes have milder symptoms, especially if certain “seizure-prone” regions are spared, but seizures and delays can still occur [14][12].

Every child is unique. A clinical geneticist cannot perfectly predict a child’s individual potential or outcome from deletion size alone [14].

Why Parental Testing Should Be Offered

After a child is diagnosed, doctors strongly recommend chromosome testing (a karyotype) for both parents [15]. This is not to assign blame, but to understand how the deletion happened, which is vital for understanding recurrence risks.

  • De Novo (Estimated ~90% of cases): Most WHS deletions are “de novo,” meaning they happened by chance in the sperm or egg that formed the child. The parents’ chromosomes are typical, and the risk of having another child with WHS is low (though not exactly zero, due to the rare possibility of germline mosaicism) [16].
  • Balanced Translocation (Estimated ~10% of cases): In some cases, a parent carries a balanced translocation. This means they have all their genetic material, but two pieces of different chromosomes have swapped places. The parent is healthy, but they have a higher risk of passing on an “unbalanced” set (like a 4p deletion) to a child [17][15].

If a balanced translocation is found, a genetic counselor can help calculate specific recurrence risks and discuss reproductive options.

Common questions in this guide

What genetic change causes Wolf-Hirschhorn syndrome?
Wolf-Hirschhorn syndrome occurs when a piece of the short arm of chromosome 4 is missing at 4p16.3. The missing segment can include several nearby genes, so the condition reflects the combined effects of losing that genetic material.
What can a chromosomal microarray show in Wolf-Hirschhorn syndrome?
A chromosomal microarray scans the genome and can identify the location and exact size of a deletion. It may not detect a balanced chromosome swap because that type of change does not add or remove genetic material.
Can the size of a Wolf-Hirschhorn deletion predict how severe the condition will be?
Larger deletions, especially those over 9 megabases, are often associated with more significant developmental delays and more frequent or severe epilepsy. However, deletion size is not a precise prediction of an individual child’s abilities, symptoms, or future health.
What is the difference between a terminal and an interstitial 4p deletion?
A terminal deletion removes genetic material from the end of the chromosome arm, while an interstitial deletion removes a segment from the middle. Interstitial deletions may sometimes cause milder features when certain regions are preserved, but seizures and developmental delays can still occur.
Why should both parents have chromosome testing after a child is diagnosed with WHS?
Testing can show whether the deletion happened by chance in the child or is related to a balanced chromosome swap carried by a parent. A parent with a balanced translocation may be healthy but have a higher chance of passing on an unbalanced chromosome change. The results help a genetic counselor estimate recurrence risk and discuss family-planning options.
What is the chance that another child will have Wolf-Hirschhorn syndrome?
About 90% of Wolf-Hirschhorn deletions are de novo, meaning they arise in the egg, sperm, or early development rather than being found in a parent’s usual chromosome test. Recurrence risk is generally low but not zero, while a parental balanced translocation can make the risk higher and requires individualized counseling.
What do the NSD2, LETM1, and MSX1 genes have to do with WHS?
Loss of NSD2 is associated with characteristic facial features, slow growth, and developmental delays, while loss of LETM1 has been proposed as a contributor to seizure susceptibility. Loss of MSX1 may contribute to dental or facial findings, but these gene associations cannot precisely predict an individual child’s features.

Get notified when new evidence is published on Wolf-Hirschhorn syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.

    Wiel LC, Bruno I, Barbi E, Sirchia F

    Italian journal of pediatrics 2022; (48(1)):72 doi:10.1186/s13052-022-01267-w.

    PMID: 35550183
  2. 2

    Disorders of sex development in Wolf-Hirschhorn syndrome: a genotype-phenotype correlation and MSX1 as candidate gene.

    Rjiba K, Ayech H, Kraiem O, et al.

    Molecular cytogenetics 2021; (14(1)):12 doi:10.1186/s13039-021-00531-8.

    PMID: 33627176
  3. 3

    De novo truncating variants in WHSC1 recapitulate the Wolf-Hirschhorn (4p16.3 microdeletion) syndrome phenotype.

    Derar N, Al-Hassnan ZN, Al-Owain M, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(1)):185-188 doi:10.1038/s41436-018-0014-8.

    PMID: 29892088
  4. 4

    Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.

    Zanoni P, Steindl K, Sengupta D, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(8)):1474-1483 doi:10.1038/s41436-021-01158-1.

    PMID: 33941880
  5. 5

    Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement.

    Kaiyrzhanov R, Mohammed SEM, Maroofian R, et al.

    American journal of human genetics 2022; (109(9)):1692-1712 doi:10.1016/j.ajhg.2022.07.007.

    PMID: 36055214
  6. 6

    Clinical and genetic characterization of ten Egyptian patients with Wolf-Hirschhorn syndrome and review of literature.

    Mekkawy MK, Kamel AK, Thomas MM, et al.

    Molecular genetics & genomic medicine 2021; (9(2)):e1546 doi:10.1002/mgg3.1546.

    PMID: 33217222
  7. 7

    MSX1 gene in the etiology orofacial deformities.

    Paradowska-Stolarz A

    Postepy higieny i medycyny doswiadczalnej (Online) 2015; (69()):1499-504.

    PMID: 27259221
  8. 8

    Prenatal diagnosis of Wolf-Hirschhorn syndrome: Ultrasonography and molecular karyotyping results.

    Zhen L, Fan SS, Huang LY, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2018; (225()):19-21 doi:10.1016/j.ejogrb.2018.03.047.

    PMID: 29626710
  9. 9

    [Study on clinical features and diagnostic methods of prenatal Wolf-Hirschhorn syndrome].

    Wang Y, Chen X, Xue H, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021; (38(8)):735-739 doi:10.3760/cma.j.cn511374-20200319-00183.

    PMID: 34365613
  10. 10

    Analyses of Genotypes and Phenotypes of Ten Chinese Patients with Wolf-Hirschhorn Syndrome by Multiplex Ligation-dependent Probe Amplification and Array Comparative Genomic Hybridization.

    Yang WX, Pan H, Li L, et al.

    Chinese medical journal 2016; (129(6)):672-8 doi:10.4103/0366-6999.177996.

    PMID: 26960370
  11. 11

    Partial Monosomy 4p and Trisomy 12q due to a t(4;12)(p16.3;q24.31) Familial Translocation in Two Cousins.

    Mozer Joaquim T, Paiva Grangeiro CH, Gaona de Oliveira Gennaro F, et al.

    Molecular syndromology 2020; (10(5)):264-271 doi:10.1159/000501923.

    PMID: 32021597
  12. 12

    Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature.

    Blanco-Lago R, Málaga I, Tenorio-Castaño JA, et al.

    Journal of clinical medicine 2025; (14(22)) doi:10.3390/jcm14228044.

    PMID: 41303083
  13. 13

    Clinician-Based Functional Scoring and Genomic Insights for Prognostic Stratification in Wolf-Hirschhorn Syndrome.

    Nevado J, Blanco-Lago R, Bel-Fenellós C, et al.

    Genes 2025; (16(7)) doi:10.3390/genes16070820.

    PMID: 40725476
  14. 14

    Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome.

    Ho KS, South ST, Lortz A, et al.

    Journal of medical genetics 2016; (53(4)):256-63 doi:10.1136/jmedgenet-2015-103626.

    PMID: 26747863
  15. 15

    Wolf-Hirschhorn syndrome: A case series from India.

    Chaudhry C, Kaur A, Panigrahi I, Kaur A

    American journal of medical genetics. Part A 2020; (182(12)):3048-3051 doi:10.1002/ajmg.a.61856.

    PMID: 32914558
  16. 16

    Wolf-Hirschhorn syndrome: Prenatal diagnosis and molecular cytogenetic characterization of a de novo distal deletion of 4p (4p16.1 → pter) in a fetus with facial cleft and preaxial polydactyly.

    Chen CP, Wang LK, Chern SR, et al.

    Taiwanese journal of obstetrics & gynecology 2020; (59(3)):425-431 doi:10.1016/j.tjog.2020.03.016.

    PMID: 32416892
  17. 17

    Wolf-Hirschhorn Syndrome with Epibulbar Dermoid: An Unusual Association in a Patient with 4p Deletion and Functional Xp Disomy.

    Bragagnolo S, Colovati ME, Guilherme RS, et al.

    Cytogenetic and genome research 2016; (150(1)):17-22 doi:10.1159/000452237.

    PMID: 27842301

This page about Wolf-Hirschhorn syndrome genetics and testing is for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your child’s results and recurrence risk.